Annie is co-mentored post-doctoral fellow in Drs. Marcia Haigis and Bernardo Sabatini laboratories. She completed her M.D. at Tzu Chi University in Taiwan and then she pursued her Ph.D. at Johns Hopkins University under the supervision of Dr. Chi Dang, where she studied MYC disruption of molecular clock in cancer cells. In collaboration with Dr. Amita Sehgal, she also found drosophila Myc is required in maintaining circadian behavior and metabolism in fruit flies.
James is a co-mentored post-doctoral fellow in Drs. Marcia Haigis and Arlene Sharpe laboratories. He completed his BSc at McMaster University, and MSc and PhD at the University of Toronto. Under the supervision of Dr. Pamela Ohashi and mentorship/guidance from Drs. Tak Mak and Naoto Hirano, his doctoral research focused on developing strategies to overcome T cell tolerance in the tumor microenvironment. James joined the Haigis and Sharpe labs to further understand how tumor microenvironment and anti-tumor immunity change with aging.
Brandon is a co-mentored post-doc between the Haigis and Gygi labs. As an undergrad at BYU, Brandon worked with Emily Bates studying the role of inwardly rectifying potassium channels in Drosphila development. He did his Ph.D at Yale with Jesse Rinehart, studying mechanisms of insulin resistance by phosphoproteomic analysis. He is currently interested in developing methods to functionalize protein phosphorylation.
Fun Fact: As an undergrad, Brandon also performed with the International Folk Dance Ensemble.
Originally from the Netherlands, Jiska performed her Ph.D. research with Prof.
Yu Hui received his PhD from Harvard University, where he studied how immune cells modulate inflammatory bowel disease. In the Haigis lab, Yu Hui will coordinate various metabolomic platforms and investigate how cytokines regulate immune cell metabolism.
Regularly causes eye-rolls by: telling bad jokes
Jaime was born and raised in Florida, completed her undergraduate degree in Biochemistry at Northwestern University, and her MD and PhD degrees at Albert Einstein College of Medicine. After training in internal medicine at MGH, she matriculated into the hematology/oncology fellowship program at DFCI and is particularly interested in thoracic oncology. She joined the Haigis lab to study mechanisms of metabolic and proteostasis dysregulation in cancer and the interplay between oncogenesis and aging.
Spirit animal: The Dachshund
Zhennan (aka Jeff) completed his PhD at Fudan University in China, where he studied the regulation of RNA/DNA modifications in stem cells and cancer cells. In his postdoc, he is interested in the interplay between cellular metabolism and epigenetic regulation in different physiological and pathological processes, such as aging and cancer.
Favorite underrated soccer player: Messi
Conghui completed her PhD at Washington University in St. Louis, where she worked on LC/MS based metabolomics of cancer cells. In her postdoc, Conghui is interested in studying how immune cell functions are comprised in the tumor microenvironment.
Ilaria was born in Italy and received her Ph.D. at the VIB of Leuven, in Belgium. During her studies, she investigated how metabolism defines a cancer phenotype and discovered two metabolic pathways that can be targeted to impair metastasis formation. As a postdoctoral researcher, she would like to link metabolic pathways to immune system regulation in order to identify effective therapeutic strategies.
Kiran completed his Ph.D at Mayo Clinic in the lab of Taro Hitosugi, studying how oncogenic signals modulate mitochondrial metabolism. Kiran's current work focuses on areas of immunometabolism, primarily investigating various cell-intrinsic metabolic processes that can influence the performance of immune cell function with the goal of exploiting these alterations for clinical intervention. Kiran is a Gilead Sciences fellow of the